Research News

---

Topic: Chemotherapy (view all topics)

Tags for topic Chemotherapy:

• Abraxane (chemical name: paclitaxel)
• Adjuvant
• Adriamycin (chemical name: doxorubicin)
• Anthracyclines
• carboplatin (brand name: Paraplatin)
• Cytoxan (chemical name: cyclophosphamide)
• daunorubicin (brand names: Cerubidine, DaunoXome)
• Dose Dense
• Doxil (chemical name: doxorubicin)
• Ellence (chemical name: epirubicin)
• fluorouracil (also called 5-fluorouracil or 5-FU; brand name: Adrucil)
• Halaven (chemical name: eribulin)
• Ixempra (chemical name: ixabepilone)
• mitoxantrone (brand name: Novantrone)
• Navelbine (chemical name: vinorelbine)
• Neoadjuvant
• Standard
• Taxanes
• Taxol (chemical name: paclitaxel)
• Taxotere (chemical name: docetaxel)
• Xeloda (chemical name: capecitabine)

View articles by month and year

• Weekly Low-Dose Taxol Offers Same Benefits as Higher Dose Every Two Weeks with Different Side Effects

  Published on June 12, 2013 at 7:54 am

  • Tags: Dose Dense, Standard, Adriamycin (chemical name: doxorubicin), Cytoxan (chemical name: cyclophosphamide), Taxol (chemical name: paclitaxel), and Adjuvant

  A study has found that getting Taxol (chemical name: paclitaxel) at a lower dose weekly offers the same benefits as getting a higher dose every 2 weeks.

• Black Women Are More Likely to Delay Chemotherapy

  Published on May 31, 2013 at 5:00 am

  • Tags: Adjuvant

  Black women are more likely than white women to delay chemotherapy; better communication between doctors and patients may help reduce this delay.

• Study Finds Scientific Basis for Chemo Brain

  Published on April 25, 2013 at 7:57 am

  • Tags: Memory loss, Standard, and Adjuvant

  A study has found a link between chemo brain and lower neuropsychological test scores.

• Taxol Plus Tykerb Better Than Taxol Alone to Treat HER2-Positive, Metastatic Disease

  Published on April 8, 2013 at 9:51 am

  • Tags: Taxol (chemical name: paclitaxel) and Tykerb

  The combination of Taxol and Tykerb offers more benefits in treating newly diagnosed metastatic, HER2-positive breast cancer than Taxol alone.

• Chemo After Surgery for Locally Recurrent Breast Cancer Improves Survival

  Published on January 31, 2013 at 4:24 am

  • Tags: Standard and Adjuvant

  A study suggests that chemotherapy after surgery for locally recurrent breast cancer improves both disease-free survival and overall survival.

• Women Taking Statins Have Fewer Heart Problems During Anthracycline Chemotherapy

  Published on January 14, 2013 at 5:59 am

  • Tags: Anthracyclines, Standard, Adriamycin (chemical name: doxorubicin), Doxil (chemical name: doxorubicin), Ellence (chemical name: epirubicin), and Heart problems

  A study found that women who were taking a statin during and after being treated for breast cancer with anthracycline chemotherapy had fewer heart problems than women who weren’t taking a statin.

• Older Women Commonly Treated with Chemotherapy Medicines Used “Off-Label”

  Published on January 11, 2013 at 4:33 am

  • Tags:

  A study found that 19% of chemotherapy medicines given to women 65 and older were used off-label.

• Dose-Dense Ellence Regimen Better for High-Risk Breast Cancer Than Early-Stage Breast Cancer

  Published on December 20, 2012 at 5:14 am

  • Tags: Dose Dense, Ellence (chemical name: epirubicin), and Adjuvant

  Two studies looking at a dose-dense regimen of Ellence compared to a standard schedule found that the dose-dense regimen is better for high-risk breast cancer.

• Study Finds Physical Evidence That Chemo Brain is Real

  Published on December 17, 2012 at 9:57 am

  • Tags: Standard, Adjuvant, and Memory loss

  A study found that chemo brain is associated with changes in the way parts of the brain use glucose.

• Chemotherapy Slightly Ups Risk of Leukemia

  Published on December 16, 2012 at 5:59 am

  • Tags: Standard and Adjuvant

  Chemotherapy slightly increases the risk of leukemia later in life.